Hemply Balance Holding
0.02 SEK
0.00 %
Less than 1K followers
HMPLY
NGM Growth Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hemply Balance Holding
| Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 1.2 | 0.3 | 0.1 | 0.2 | 0.3 | 0.8 | 0.2 |
| EBITDA | -1.2 | -0.6 | -0.1 | -0.2 | -0.2 | -0.0 | -0.5 | -0.1 |
| EBIT | -0.0 | -0.6 | -0.1 | -0.2 | -0.2 | -0.0 | -0.5 | -0.1 |
| EBIT-% | -27.3 % | -53.4 % | -36.0 % | -250.0 % | -109.1 % | -0.9 % | -56.4 % | -29.6 % |
| Profit before taxes | -0.0 | -0.6 | -0.1 | -0.2 | -0.2 | -0.0 | -0.5 | -0.1 |
| Net income | -0.0 | -0.6 | -0.1 | -0.2 | -0.2 | -0.0 | -0.5 | -0.1 |